Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Media Coverage

The Bottom Line quotes Pierre Lefebvre in an article about Therathechnologies’ victory before the Supreme Court of Canada

Fasken
Reading Time 1 minute read
Subscribe
“Class action suit rules tightened in SCC Pharma case” by Luis Milan, The Bottom Line

Read the article

The Bottom Line quotes Pierre Lefebvre, a partner and litigator at Fasken Martineau’s office in Montreal, in an article about the Supreme Court of Canada’s decision to dismiss the proposed securities class action against Therathechnologies Inc. The article also examines the repercussions the SCC ruling may have on similar lawsuits in the future.

    Subscribe

    Receive email updates from our team

    Subscribe